International Lung Screen Trial (ILST)

NAActive, not recruitingINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

April 5, 2017

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Non-small Cell Lung CancerLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesSmokers at Risk of Lung Cancer
Interventions
DIAGNOSTIC_TEST

Low dose CT

low-dose screening CT of chest for lung cancer detection

Trial Locations (6)

2010

St Vincent's Hospital, Sydney

3050

Royal Melbourne Hospital, Melbourne

4032

The Prince Charles Hospital, Brisbane

6009

Sir Charles Gairdner Hospital, Perth

6150

Fiona Stanley Hospital, Perth

V5Z1L3

BC Cancer Research Centre, Vancouver

All Listed Sponsors
lead

The University of Queensland

OTHER

NCT02871856 - International Lung Screen Trial (ILST) | Biotech Hunter | Biotech Hunter